Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FQT4V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,323
Award facts
- Contract value 100% obligated
- $30,323.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,323.35 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on January 5, 2026, with completion scheduled for January 6, 2026. TALTZ is a prescription injectable medication used to treat autoimmune conditions. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
This delivery order is fulfilled through AmerisourceBergen's comprehensive Pharmaceutical Prime Vendor Global Program contract with the Defense Logistics Agency, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The firm fixed pricing structure and expedited completion timeline reflect the urgent medical supply needs of the Defense Health Agency and other federal healthcare customers. AmerisourceBergen's established capability to meet federal procurement requirements through open competition, demonstrated across its extensive portfolio of medical product deliveries, positions the company as a key supplier within the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQT4V?
SPE2DR26FQT4V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FQT4V worth?
The government has obligated $30,323 on SPE2DR26FQT4V.
Is contract SPE2DR26FQT4V an order under another contract?
Yes. SPE2DR26FQT4V is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT4V competed?
The extent of competition for SPE2DR26FQT4V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award